IMTX
Price
$7.71
Change
+$0.65 (+9.22%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
856.99M
53 days until earnings call
OTLC
Price
$0.07
Change
-$0.00 (-0.00%)
Updated
Sep 25 closing price
Capitalization
31.87M
59 days until earnings call
Interact to see
Advertisement

IMTX vs OTLC

Header iconIMTX vs OTLC Comparison
Open Charts IMTX vs OTLCBanner chart's image
Immatics
Price$7.71
Change+$0.65 (+9.22%)
Volume$10.47K
Capitalization856.99M
Oncotelic Therapeutics
Price$0.07
Change-$0.00 (-0.00%)
Volume$195.95K
Capitalization31.87M
IMTX vs OTLC Comparison Chart in %
Loading...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OTLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMTX vs. OTLC commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMTX is a Buy and OTLC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (IMTX: $7.05 vs. OTLC: $0.07)
Brand notoriety: IMTX and OTLC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMTX: 64% vs. OTLC: 129%
Market capitalization -- IMTX: $856.99M vs. OTLC: $31.87M
IMTX [@Biotechnology] is valued at $856.99M. OTLC’s [@Biotechnology] market capitalization is $31.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMTX’s FA Score shows that 0 FA rating(s) are green whileOTLC’s FA Score has 0 green FA rating(s).

  • IMTX’s FA Score: 0 green, 5 red.
  • OTLC’s FA Score: 0 green, 5 red.
According to our system of comparison, IMTX is a better buy in the long-term than OTLC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMTX’s TA Score shows that 5 TA indicator(s) are bullish while OTLC’s TA Score has 6 bullish TA indicator(s).

  • IMTX’s TA Score: 5 bullish, 5 bearish.
  • OTLC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, OTLC is a better buy in the short-term than IMTX.

Price Growth

IMTX (@Biotechnology) experienced а +6.66% price change this week, while OTLC (@Biotechnology) price change was +7.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +9.02%, and the average quarterly price growth was +51.46%.

Reported Earning Dates

IMTX is expected to report earnings on Nov 18, 2025.

OTLC is expected to report earnings on Nov 24, 2025.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMTX($857M) has a higher market cap than OTLC($31.9M). OTLC YTD gains are higher at: 109.371 vs. IMTX (-0.844). OTLC has higher annual earnings (EBITDA): -3.36M vs. IMTX (-58.05M). IMTX has more cash in the bank: 478M vs. OTLC (88K). OTLC has less debt than IMTX: OTLC (13.5M) vs IMTX (17.1M). IMTX has higher revenues than OTLC: IMTX (130M) vs OTLC (0).
IMTXOTLCIMTX / OTLC
Capitalization857M31.9M2,687%
EBITDA-58.05M-3.36M1,727%
Gain YTD-0.844109.371-1%
P/E Ratio27.61N/A-
Revenue130M0-
Total Cash478M88K543,182%
Total Debt17.1M13.5M127%
FUNDAMENTALS RATINGS
IMTX vs OTLC: Fundamental Ratings
IMTX
OTLC
OUTLOOK RATING
1..100
2023
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
52
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9597
PRICE GROWTH RATING
1..100
3937
P/E GROWTH RATING
1..100
5994
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OTLC's Valuation (52) in the null industry is in the same range as IMTX (57). This means that OTLC’s stock grew similarly to IMTX’s over the last 12 months.

OTLC's Profit vs Risk Rating (100) in the null industry is in the same range as IMTX (100). This means that OTLC’s stock grew similarly to IMTX’s over the last 12 months.

IMTX's SMR Rating (95) in the null industry is in the same range as OTLC (97). This means that IMTX’s stock grew similarly to OTLC’s over the last 12 months.

OTLC's Price Growth Rating (37) in the null industry is in the same range as IMTX (39). This means that OTLC’s stock grew similarly to IMTX’s over the last 12 months.

IMTX's P/E Growth Rating (59) in the null industry is somewhat better than the same rating for OTLC (94). This means that IMTX’s stock grew somewhat faster than OTLC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMTXOTLC
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 12 days ago
79%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OTLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRPPX15.89N/A
N/A
Principal International Equity R3
PGUCX15.85N/A
N/A
Virtus Duff & Phelps Global Infras C
MUEVX41.18N/A
N/A
MFS Blended Research Core Equity R6
ISIIX13.25N/A
N/A
Voya International Index Port S2
FIKVX14.29N/A
N/A
Fidelity Advisor Asset Manager 20% Z

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with IDYA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
-3.82%
IDYA - IMTX
52%
Loosely correlated
+0.08%
OCUL - IMTX
52%
Loosely correlated
-2.55%
IMNM - IMTX
48%
Loosely correlated
-9.33%
RGNX - IMTX
48%
Loosely correlated
-1.89%
CRNX - IMTX
48%
Loosely correlated
+2.02%
More

OTLC and

Correlation & Price change

A.I.dvisor tells us that OTLC and TENX have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OTLC and TENX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLC
1D Price
Change %
OTLC100%
+3.43%
TENX - OTLC
23%
Poorly correlated
+4.77%
MNKD - OTLC
22%
Poorly correlated
N/A
IMTX - OTLC
21%
Poorly correlated
-3.82%
MMIRF - OTLC
15%
Poorly correlated
N/A
IPHYF - OTLC
4%
Poorly correlated
N/A
More